Inhibition of miR-129 by miR-129 antagomir could attenuate NLRP3/caspase-1 mediated pyroptosis and improve cognitive impairment by activating IGF-1/GSK3β signaling pathway via directly targeting IGF-1 (Wang et al., 2021). The gene discussed is CASP1; the disease is Cognitive impairment.